These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 831078)
1. Human disease transferred to mice: myasthenia gravis. Dawson DM N Engl J Med; 1977 Jan; 296(3):168-9. PubMed ID: 831078 [No Abstract] [Full Text] [Related]
2. Editorial: Cause of weakness in myasthenia gravis. Grob D N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544 [No Abstract] [Full Text] [Related]
9. Autoantibodies in myasthenia gravis: demonstration of anti-motor endplate antibody and anti-muscle membrane antibody using membrane immunofluorescence technique. Arimori S; Tada S; Nakata Y; Kobashi H; Ichikawa Y Acta Med Okayama; 1975 Dec; 29(6):397-404. PubMed ID: 132840 [TBL] [Abstract][Full Text] [Related]
10. Time course of neonatal myasthenia gravis and unsuspectedly long duration of neuromuscular block in distal muscles. Desmedt JE; Borenstein S N Engl J Med; 1977 Mar; 296(11):633. PubMed ID: 190536 [No Abstract] [Full Text] [Related]
11. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis. Heilbronn E Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612 [No Abstract] [Full Text] [Related]
12. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)]. Hohlfeld R; Wekerle H MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965 [TBL] [Abstract][Full Text] [Related]
13. The immunopathology of myasthenia gravis. Engel AG Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990 [No Abstract] [Full Text] [Related]
14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model. Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263 [TBL] [Abstract][Full Text] [Related]
16. Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses. Christadoss P; Lindstrom J; Munro S; Talal N J Neuroimmunol; 1985 Apr; 8(1):29-41. PubMed ID: 3973007 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis]. Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871 [No Abstract] [Full Text] [Related]
18. Letter: Acetylcholine-receptor-blocking factor and striated-muscle antibody in myasthenia gravis. Strauss AJ Lancet; 1976 Jun; 1(7974):1405-6. PubMed ID: 59037 [No Abstract] [Full Text] [Related]
19. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Mossman S; Vincent A; Newsom-Davis J Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076 [TBL] [Abstract][Full Text] [Related]
20. Experimental myasthenia gravis: a model of receptor disease. Takamori M; Kasai M Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991 [No Abstract] [Full Text] [Related] [Next] [New Search]